ABSTRACTAimKampo medicines are effective depending on the combination of crude drugs. In addition, the basis is a combination of two crude drugs, which is defined as a ‘herbal pair’. However, there are very few studies from this point of view. We found that Rhei Rhizoma (RR) may interact with Coptidis Rhizoma (CR).MethodsComponent profiles were analyzed by three‐dimensional high‐performance liquid chromatography (3D‐HPLC). Cell viability in N18TG‐2 cells was determined by morphology observation and a ‘3‐(4,5‐di‐methylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide, yellow tetrazole (MTT)’ assay.ResultsWhen RR and CR were extracted together, the color of the extract was lighter than the colors of the individual extracts. In addition, precipitation occurred by simply combining the extracts of both in vitro. When each component profile was analyzed by 3D‐HPLC, at least the amount of berberine, which is contained in a large amount in CR, was strongly decreased in combined extracts with RR. Although CR and RR each have a cytotoxic effect, when both were extracted together, their cytotoxicity almost disappeared. However, cytotoxicity remained in the supernatant when both extracts were combined in vitro, and also in the suspension of the resulting precipitate.ConclusionFrom these results, when CR and RR are extracted together, their cytotoxicity is suppressed by some unknown mechanism. Whether this is due to the synthesis of new compounds by co‐extraction or the detoxification of toxic components by interaction needs further investigation. This result suggests the importance of ‘herbal pair’ research.
Read full abstract